Nature Communications (May 2022)

Comparative effectiveness over time of the mRNA-1273 (Moderna) vaccine and the BNT162b2 (Pfizer-BioNTech) vaccine

  • Nazmul Islam,
  • Natalie E. Sheils,
  • Megan S. Jarvis,
  • Kenneth Cohen

DOI
https://doi.org/10.1038/s41467-022-30059-3
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 7

Abstract

Read online

In this retrospective cohort study, Islam et al. estimate the effectiveness of two mRNA-based COVID-19 vaccines in over 3.5 million fully vaccinated individuals and find no differences in vaccine effectiveness for protection against hospitalization, ICU admission, or death/hospice transfer.